Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'VONWILLEBRAND-FACTOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2275 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Laughlin, MH; Pollock, JS; Amann, JF; Hollis, ML; Woodman, CR; Price, EM
      Training induces nonuniform increases in eNOS content along the coronary arterial tree

      JOURNAL OF APPLIED PHYSIOLOGY
    2. Pastacaldi, S; Teixeira, R; Montalto, P; Rolles, K; Burroughs, AK
      Hepatic artery thrombosis after orthotopic liver transplantation: A reviewof nonsurgical causes

      LIVER TRANSPLANTATION
    3. Goodeve, A; Peake, I
      A standard nomenclature for von Willebrand factor gene mutations and polymorphisms

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    4. de Wit, TR; van Mourik, JA
      Biosynthesis, processing and secretion of von Willebrand factor: biological implications

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    5. Ruggeri, ZM
      Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    6. Schneppenheim, R; Budde, U; Ruggeri, ZM
      A molecular approach to the classification of von Willebrand disease

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    7. Favaloro, EJ
      Appropriate laboratory assessment as a critical facet in the proper diagnosis and classification of von Willebrand disorder

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    8. Mazurier, C; Goudemand, J; Hilbert, L; Caron, C; Fressinaud, E; Meyer, D
      Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    9. Furlan, M; Lammle, B
      Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    10. Scheja, A; Akesson, A; Geborek, P; Wildt, M; Wollheim, CB; Wollheim, FA; Vischer, UM
      Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)

      ARTHRITIS RESEARCH
    11. You, Y; Liao, FL
      In vitro-inhibition of shear-induced platelet aggregation by verapamil

      CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    12. Alberth, G; Kettisen, J; Lisander, B
      Blood loss in prosthetic hip replacement is not influenced by the AB0 blood group

      EUROPEAN JOURNAL OF SURGERY
    13. Kolkman, JA; Stemmer, WPC
      Directed evolution of proteins by exon shuffling

      NATURE BIOTECHNOLOGY
    14. de Leeuw, HPJC; Fernandez-Borja, M; Reits, EAJ; de Wit, TR; Wijers-Koster, PM; Hordijk, PL; Neefjes, J; van Mourik, JA; Voorberg, J
      Small GTP-binding protein Ral modulates regulated exocytosis of von Willebrand factor by endothelial cells

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    15. Kamphuisen, PW; Eikenboom, JCJ; Bertina, RM
      Elevated factor VIII levels and the risk of thrombosis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    16. Abulencia, JP; Tien, N; McCarty, OJT; Plymire, D; Mousa, SA; Konstantopoulos, K
      Comparative antiplatelet efficacy of a novel, nonpeptide GPIIb/IIIa antagonist (XV454) and abciximab (c7E3) in flow models of thrombosis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    17. Savasan, S; Taub, JW; Buck, S; Botterill, M; Furlan, M; Ravindranath, Y
      Congenital microangiopathic hemolytic anemia and thrombocytopenia with unusually large von Willebrand factor multimers and von willebrand factor-cleaving protease

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    18. Casonato, A; Pontara, E; Vertolli, UP; Steffan, A; Durante, C; De Marco, L; Sartorello, F; Girolami, A
      Plasma and platelet von Willebrand factor abnormalities in patients with uremia: Lack of correlation with uremic bleeding

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    19. Savage, B; Cattaneo, M; Ruggeri, ZM
      Mechanisms of platelet aggregation

      CURRENT OPINION IN HEMATOLOGY
    20. Nagel, RL
      Pleiotropic and epistatic effects in sickle cell anemia

      CURRENT OPINION IN HEMATOLOGY
    21. Voura, EB; Ramjeesingh, RA; Montgomery, AMP; Siu, CH
      Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells

      MOLECULAR BIOLOGY OF THE CELL
    22. Ogawa, S; Minakami, H; Araki, S; Ohno, T; Motoyama, M; Shibahara, H; Sato, I
      A rise of the serum level of von Willebrand factor occurs before clinical manifestation of the severe form of ovarian hyperstimulation syndrome

      JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
    23. Li, CQ; Ye, P; Cao, ZF; Wang, HF; Lu, L; Nicastro, P; Wood, E; Robert, JJ; Ouwehand, WH; Hill, F; Lopez, JA; Wardell, MR
      Expression of the amino-terminal domain of platelet glycoprotein Ib alpha:Exploitation of a calmodulin tag for determination of its functional activity

      PROTEIN EXPRESSION AND PURIFICATION
    24. Clutton, P; Folts, JD; Freedman, JE
      Pharmacological control of platelet function

      PHARMACOLOGICAL RESEARCH
    25. Blann, AD; Amiral, J; Taberner, DA
      Platelet and endothelial-cell markers in meningococcal septicaemia: a report of two cases

      BRITISH JOURNAL OF BIOMEDICAL SCIENCE
    26. Mahairaki, V; Lycett, G; Blass, C; Louis, C
      Beta-integrin of Anopheles gambiae: mRNA cloning and analysis of structureand expression

      INSECT MOLECULAR BIOLOGY
    27. O'Donnell, J; Laffan, MA
      The relationship between ABO histo-blood group, factor VIII and von Willebrand factor

      TRANSFUSION MEDICINE
    28. Ervin, AL; Peerschke, EIB
      Platelet activation by sustained exposure to low-dose plasmin

      BLOOD COAGULATION & FIBRINOLYSIS
    29. Praprotnik, S; Blank, M; Levy, Y; Tavor, S; Boffa, MC; Weksler, B; Eldor, A; Shoenfeld, Y
      Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells

      INTERNATIONAL IMMUNOLOGY
    30. Goto, S; Tamura, N; Sakakibara, M; Ikeda, Y; Handa, S
      Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation

      PLATELETS
    31. Eto, K; Goto, S; Shimazaki, T; Sakakibara, M; Yoshida, M; Isshiki, T; Handa, S
      Two distinct mechanisms are involved in stent thrombosis under flow conditions

      PLATELETS
    32. Mohammed, FI; Shafagoj, YA
      Antiaggregation effect of alum on human platelets

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    33. Sabatelli, P; Bonaldo, P; Lattanzi, G; Braghetta, P; Bergamin, N; Capanni, C; Mattioli, E; Columbaro, M; Ognibene, A; Pepe, G; Bertini, E; Merlini, L; Maraldi, NM; Squarzoni, S
      Collagen VI deficiency affects the organization of fibronectin in the extracellular matrix of cultured fibroblasts

      MATRIX BIOLOGY
    34. Kallas, A; Talpsep, T
      The von Willebrand factor collagen-binding activity assay: clinical application

      ANNALS OF HEMATOLOGY
    35. Casana, P; Martinez, F; Haya, S; Espinos, C; Aznar, JA
      Association of the 3467C > T mutation (T1156M) in the von Willebrand's factor gene with dominant type 1 von Willebrand's disease

      ANNALS OF HEMATOLOGY
    36. Rendal, E; Penas, N; Larrabeiti, B; Perez, A; Vale, A; Lopez-Fernandez, MF; Batlle, J
      Type 2B von Willebrand's disease due to Val1316Met mutation. Heterogeneityin the same sibship

      ANNALS OF HEMATOLOGY
    37. Christensson, AG; Danielson, BG; Lethagen, SR
      Normalization of haemoglobin concentration with recombinant erythropoietinhas minimal effect on blood haemostasis

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    38. Liu, JX; Hutzler, M; Li, CZ; Pechet, L
      Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): The new thinking

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    39. Sugio, Y; Okamura, T; Shimoda, K; Matsumoto, M; Yagi, H; Ishizashi, H; Niho, Y; Inaba, S; Fujimura, Y
      Ticlopidine-associated thrombotic thrombocytopenic purpura with an IgG-type inhibitor to von Willebrand factor-cleaving protease activity

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    40. Kinoshita, S; Yoshioka, A; Park, YD; Ishizashi, H; Konno, M; Funato, M; Matsui, T; Titani, K; Yagi, H; Matsumoto, M; Fujimura, Y
      Upshaw-Schulman syndrome revisited: A concept of congenital thrombotic thrombocytopenic purpura

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    41. Sasahara, Y; Kumaki, S; Ohashi, Y; Minegishi, M; Kano, H; Bessho, F; Tsuchiya, S
      Deficient activity of von Willebrand factor-cleaving protease in patients with Upshaw-Schulman syndrome

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    42. Shinagawa, A; Kojima, H; Kobayashi, T; Kawada, K; Nagasawa, T
      Lupus anticoagulant-like activity observed in a dimeric lambda protein produced by myeloma cells

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    43. Mine, S; Fujisaki, T; Suematsu, M; Tanaka, Y
      Activated platelets and endothelial cell interaction with neutrophils under flow conditions

      INTERNAL MEDICINE
    44. Suter, CM; Hogg, PJ; Price, JT; Chong, BH; Ward, RL
      Identification and characterisation of a platelet GPIb/V/IX-like complex on human breast cancers: Implications for the metastatic process

      JAPANESE JOURNAL OF CANCER RESEARCH
    45. Seebach, JD; Schneider, MKJ; Comrack, CA; LeGuern, A; Kolb, SA; Knolle, PA; Germana, S; DerSimonian, H; LeGuern, C; Sachs, DH
      Immortalized bone-marrow derived pig endothelial cells

      XENOTRANSPLANTATION
    46. Louden, C; Morgan, DG
      Pathology and pathophysiology of drug-induced arterial injury in laboratory animals and its implications on the evaluation of novel chemical entitiesfor human clinical trials

      PHARMACOLOGY & TOXICOLOGY
    47. Andrades, JA; Wu, LT; Hall, FL; Nimni, ME; Becerra, J
      Engineering, expression, and renaturation of a collagen-targeted human bFGF fusion protein

      GROWTH FACTORS
    48. Escolar, G; Galan, AM; Mazzara, R; Castillo, R; Ordinas, A
      Measurement of platelet interactions with subendothelial substrata: Relevance to transfusion medicine

      TRANSFUSION MEDICINE REVIEWS
    49. Mitterbauer, M; Neumeister, P; Kalhs, P; Brugger, S; Fischer, C; Dieckmann, K; Hoecker, P; Hinterberger, W; Linkesch, W; Simonitsch, I; Jaeger, U; Lechner, K; Mannhalter, C; Mitterbauer, G; Greinix, HT
      Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma

      LEUKEMIA
    50. Roschitz, B; Sudi, K; Kostenberger, M; Muntean, W
      Shorter PFA-100((R)) closure times in neonates than in adults: role of redcells, white cells, platelets and von Willebrand factor

      ACTA PAEDIATRICA
    51. Mustafa, A; Hamsten, A; Holm, G; Lefvert, AK
      Circulating immune complexes induced by food proteins implicated in precocious myocardial infarction

      ANNALS OF MEDICINE
    52. Fukuchi, M; Watanabe, J; Kumagai, K; Katori, Y; Baba, S; Fukuda, K; Yagi, T; Iguchi, A; Yokoyama, H; Miura, M; Kagaya, Y; Sato, S; Tabayashi, K; Shirato, K
      Increased von Willebrand factor in the endocardium as a local predisposingfactor for thrombogenesis in overloaded human atrial appendage

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    53. Chemnitz, J; Schulz, A; Diehl, V; Sohngen, D
      Thrombotic thrombocytopenic purpura (Moschcowitz' syndrome)

      MEDIZINISCHE KLINIK
    54. Lee, YJ; Shin, KC; Kang, SW; Lee, EB; Kim, HA; Song, YW
      Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    55. Casana, P; Martinez, F; Haya, S; Tavares, A; Aznar, JA
      New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease

      HAEMATOLOGICA
    56. Woods, AI; Meschengieser, SS; Blanco, AN; Salviu, MJ; Farias, CE; Kempfer, AC; Lazzari, MA
      Clinical features and laboratory patterns in a cohort of consecutive Argentinian patients with von Willebrand's disease

      HAEMATOLOGICA
    57. Villa, P; Iborra, J; Serra, J; Gilsanz, A; Casana, P; Aznar, JA; Aznar, J
      Evaluation of an automated method for the quantification of von Willebrandfactor antigen. Its application in the study of vascular dysfunction

      HAEMATOLOGICA
    58. Casonato, A; Pontara, E; Sartorello, F; Gemmati, D; Cattini, MG; Girolami, A
      Combined hemophilia A and type 2N von Willebrand's disease: defect of bothfactor VIII level and factor VIII binding capacity of von Willebrand factor

      HAEMATOLOGICA
    59. Haddad, AP; Sparrow, RL
      The short tandem repeat locus VWF2 in intron 40 of the von Willebrand factor gene consists of two polymorphic sub-loci

      FORENSIC SCIENCE INTERNATIONAL
    60. Yagi, H; Narita, N; Matsumoto, M; Sakurai, Y; Ikari, H; Yoshioka, A; Kita, E; Ikeda, Y; Titani, K; Fujimura, Y
      Enhanced low shear stress induced platelet aggregation by shiga-like toxin1 purified from Escherichia coli O157

      AMERICAN JOURNAL OF HEMATOLOGY
    61. Datta, YH; Ewenstein, BM
      Regulated secretion in endothelial cells: Biology and clinical implications

      THROMBOSIS AND HAEMOSTASIS
    62. Perrault, C; Moog, S; Rubinstein, E; Santer, M; Baas, MJ; de la Salle, C; Ravanat, C; Dambach, J; Freund, M; Santoso, S; Cazenave, JP; Lanza, F
      A novel monoclonal antibody against the extracellular domain of GPIb beta modulates vWF mediated platelet adhesion

      THROMBOSIS AND HAEMOSTASIS
    63. Wang, WJ; Huang, TF
      A novel tetrameric venom protein, agglucetin from Agkistrodon acutus, actsas a glycoprotein Ib agonist

      THROMBOSIS AND HAEMOSTASIS
    64. Ribba, AS; Loisel, I; Lavergne, JM; Juhan-Vague, I; Obert, B; Cherel, G; Meyer, D; Girma, JP
      Ser968Thr mutation within the A3 domain of von Willebrand Factor (VWF) in two related patients leads to a defective binding of VWF to collagen

      THROMBOSIS AND HAEMOSTASIS
    65. Ulrichts, H; Depraetere, H; Harsfalvi, J; Deckmyn, H
      Selection of phages that inhibit vWF interaction with collagen under both static and flow conditions

      THROMBOSIS AND HAEMOSTASIS
    66. Kasirer-Friede, A; Legrand, C; Frojmovic, MM
      Complementary roles for fibrin(ogen), thrombospondin and vWF in mediating shear-dependent aggregation of platelets stimulated at threshold thrombin concentrations

      THROMBOSIS AND HAEMOSTASIS
    67. Costa, M; Grant, PJ; Rice, GI; Futers, TS; Medcalf, RL
      Human endothelial cell-derived nuclear proteins that recognise polymorphicDNA elements in the von Willebrand factor gene promoter include YY1

      THROMBOSIS AND HAEMOSTASIS
    68. Plow, EF; Cierniewski, CS; Xiao, ZH; Haas, TA; Byzova, TV
      alpha(IIb)beta(3) and its antagonism at the new millennium

      THROMBOSIS AND HAEMOSTASIS
    69. Levy, G; Ginsburg, D
      Getting at the variable expressivity of von Willebrand disease

      THROMBOSIS AND HAEMOSTASIS
    70. Berndt, MC; Shen, Y; Dopheide, SM; Gardiner, EE; Andrews, RK
      The vascular biology of the glycoprotein Ib-IX-V complex

      THROMBOSIS AND HAEMOSTASIS
    71. Bertagna, A; Jahroudi, N
      The NFY transcription factor mediates induction of the von Willebrand factor promoter by irradiation

      THROMBOSIS AND HAEMOSTASIS
    72. Cauwenberghs, N; Schlammadinger, A; Vauterin, S; Cooper, S; Descheemaeker, G; Tornai, I; Deckmyn, H
      Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor

      THROMBOSIS AND HAEMOSTASIS
    73. Rucavado, A; Soto, M; Kamiguti, AS; Theakston, RDG; Fox, JW; Escalante, T; Gutierrez, JM
      Characterization of aspercetin, a platelet aggregating component from the venom of the snake Bothrops asper which induces thrombocytopenia and potentiates metalloproteinase-induced hemorrhage

      THROMBOSIS AND HAEMOSTASIS
    74. Remijn, JA; Wu, YP; Ijsseldijk, MJW; Zwaginga, JJ; Sixma, JJ; de Groot, PG
      Absence of fibrinogen in afibrinogenemia results in large but loosely packed thrombi under flow conditions

      THROMBOSIS AND HAEMOSTASIS
    75. Bonnefoy, A; Harsfalvi, J; Pfliegler, G; Fauvel-Lafeve, F; Legrand, C
      The subendothelium of the HMEC-1 cell line supports thrombus formation in the absence of von Willebrand factor and collagen types I, III and VI

      THROMBOSIS AND HAEMOSTASIS
    76. Osumi, K; Ozeki, Y; Saito, S; Nagamura, Y; Ito, H; Kimura, Y; Ogura, H; Nomura, S
      Development and assessment of enzyme immunoassay for platelet-derived microparticles

      THROMBOSIS AND HAEMOSTASIS
    77. Sandberg, H; Almstedt, A; Brandt, J; Gray, E; Holmquist, L; Oswaldsson, U; Sebring, S; Mikaelsson, M
      Structural and functional characteristics of the B-domain-deleted recombinant factor VIII protein, r-VIII SQ

      THROMBOSIS AND HAEMOSTASIS
    78. Gardinali, M; Pozzi, MR; Bernareggi, M; Montani, N; Allevi, E; Catena, L; Cugno, M; Bottasso, B; Stabilini, R
      Treatment of Raynaud's phenomenon with intravenous prostaglandin E-1 alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis

      JOURNAL OF RHEUMATOLOGY
    79. Davis, KR; Pearson, H; Moat, S; Bonham, JR; Donnelly, R
      Acute hyperhomocysteinaemia affects pulse pressure but not microvascular vasodilator function

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    80. Dopheide, SM; Yap, CL; Jackson, SP
      Dynamic aspects of platelet adhesion under flow

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    81. Matsui, T; Hamako, J; Ozeki, Y; Titani, K
      Comparative study of blood group-recognizing lectins toward ABO blood group antigens on neoglycoproteins, glycoproteins and complex-type oligosaccharides

      BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
    82. Noris, M; Remuzzi, G
      Familial and recurrent forms of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura

      RARE KIDNEY DISEASES
    83. Hallahan, DE; Qu, SM; Geng, L; Cmelak, A; Chakravarthy, A; Martin, W; Scarfone, C; Giorgio, T
      Radiation-mediated control of drug delivery

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    84. Goto, A; Kumagai, T; Kumagai, C; Hirose, J; Narita, H; Mori, H; Kadowaki, T; Beck, K; Kitagawa, Y
      A Drosophila haemocyte-specific protein, hemolectin, similar to human von Willebrand factor

      BIOCHEMICAL JOURNAL
    85. Escande, F; Aubert, JP; Porchet, N; Buisine, MP
      Human mucin gene MUC5AC: organization of its 5 '-region and central repetitive region

      BIOCHEMICAL JOURNAL
    86. Bell, SL; Xu, GQ; Forstner, JF
      Role of the cystine-knot motif at the C-terminus of rat mucin protein Muc2in dimer formation and secretion

      BIOCHEMICAL JOURNAL
    87. Plaimauer, B; Mohr, G; Wernhart, W; Himmelspach, M; Dorner, F; Schlokat, U
      'Shed' furin: mapping of the cleavage determinants and identification of its C-terminus

      BIOCHEMICAL JOURNAL
    88. Andrews, RK; Shen, Y; Gardiner, EE; Berndt, MC
      Platelet adhesion receptors and (patho)physiological thrombus formation

      HISTOLOGY AND HISTOPATHOLOGY
    89. Krizek, DM; Rick, ME
      Clinical application of a rapid method using agarose gel electrophoresis and Western blotting to evaluate von Willebrand factor protease activity

      ELECTROPHORESIS
    90. Yildirir, A; Tokgozoglu, SL; Oduncu, T; Oto, A; Haznedaroglu, I; Akinci, D; Koksal, G; Sade, E; Kirazli, S; Kes, S
      Soy protein diet significantly improves endothelial function and lipid parameters

      CLINICAL CARDIOLOGY
    91. Vinik, AI; Erbas, T; Park, TS; Nolan, R; Pittenger, GL
      Platelet dysfunction in type 2 diabetes

      DIABETES CARE
    92. Chaturvedi, N; Sjoelie, AK; Porta, M; Aldington, SJ; Fuller, JH; Songini, M; Kohner, EM
      Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes - The EURODIAB Prospective Complications Study

      DIABETES CARE
    93. Broberg, M; Nygren, H
      Von Willebrand factor, a key protein in the exposure of CD62P on platelets

      BIOMATERIALS
    94. Keeney, S; Cumming, AM
      The molecular biology of von Willebrand disease

      CLINICAL AND LABORATORY HAEMATOLOGY
    95. Pisoni, R; Ruggenenti, P; Remuzzi, G
      Drug-induced thrombotic microangiopathy - Incidence, prevention and management

      DRUG SAFETY
    96. Rohsig, LM; Damin, DC; Stefani, SD; Castro, CG; Roisenberg, I; Schwartsmann, G
      von Willebrand factor antigen levels in plasma of patients with malignant breast disease

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    97. Sutor, AH; Thomas, KB; Prufer, FHA; Grohmann, A; Brandis, M; Zimmerhackl, LB
      Function of von Willebrand factor in children with diarrhea-associated hemolytic-uremic syndrome (D+ HUS)

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    98. Ruggenenti, P; Noris, M; Remuzzi, G
      Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura

      KIDNEY INTERNATIONAL
    99. Bennett, JS
      Novel platelet inhibitors

      ANNUAL REVIEW OF MEDICINE
    100. Sakariassen, KS; Hanson, SR; Cadroy, Y
      Methods and models to evaluate shear-dependent and surface reactivity-dependent antithrombotic efficacy

      THROMBOSIS RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/02/20 alle ore 12:20:17